Correlation Between New Residential and SCANDMEDICAL SOLDK-040

Can any of the company-specific risk be diversified away by investing in both New Residential and SCANDMEDICAL SOLDK-040 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining New Residential and SCANDMEDICAL SOLDK-040 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between New Residential Investment and SCANDMEDICAL SOLDK 040, you can compare the effects of market volatilities on New Residential and SCANDMEDICAL SOLDK-040 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in New Residential with a short position of SCANDMEDICAL SOLDK-040. Check out your portfolio center. Please also check ongoing floating volatility patterns of New Residential and SCANDMEDICAL SOLDK-040.

Diversification Opportunities for New Residential and SCANDMEDICAL SOLDK-040

0.11

Correlation Coefficient

New Residential  SCANDMEDICAL SOLDK-040

Average diversification

The 3 months correlation between New and SCANDMEDICAL is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding New Residential Investment and SCANDMEDICAL SOLDK 040 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCANDMEDICAL SOLDK 040 and New Residential is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on New Residential Investment are associated (or correlated) with SCANDMEDICAL SOLDK-040. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCANDMEDICAL SOLDK 040 has no effect on the direction of New Residential i.e., New Residential and SCANDMEDICAL SOLDK-040 go up and down completely randomly.

Pair Corralation between New Residential and SCANDMEDICAL SOLDK-040

Assuming the 90 days trading horizon New Residential Investment is expected to generate 0.39 times more return on investment than SCANDMEDICAL SOLDK-040. However, New Residential Investment is 2.57 times less risky than SCANDMEDICAL SOLDK-040. It trades about 0.04 of its potential returns per unit of risk. SCANDMEDICAL SOLDK 040 is currently generating about -0.1 per unit of risk. If you would invest  1,021  in New Residential Investment on December 30, 2024 and sell it today you would earn a total of  25.00  from holding New Residential Investment or generate 2.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

New Residential Investment  vs.  SCANDMEDICAL SOLDK 040

New Residential Inve

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in New Residential Investment are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, New Residential is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

SCANDMEDICAL SOLDK 040

Risk-Adjusted Performance

Very Weak

Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with New Residential and SCANDMEDICAL SOLDK-040

The main advantage of trading using opposite New Residential and SCANDMEDICAL SOLDK-040 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if New Residential position performs unexpectedly, SCANDMEDICAL SOLDK-040 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCANDMEDICAL SOLDK-040 will offset losses from the drop in SCANDMEDICAL SOLDK-040's long position.

The idea behind New Residential Investment and SCANDMEDICAL SOLDK 040 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.